Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on September 17, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Kenneth Gardner-Smith named CEO, succeeding retiring Edward Pesicka in early Q4 2026.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Kenneth Gardner-Smith named CEO, succeeding retiring Edward Pesicka in early Q4 2026
- Pesicka remains advisor during transition, then retires from the Board
- Gardner-Smith retains Board and Executive Committee roles as non-independent director
- CEO compensation includes $1M salary, 130% target bonus, and $6M annual equity award
- Additional incentives include $650K sign-on bonus and $2M cash-settled stock appreciation rights
Item 7.01 · Regulation FD Disclosure
- Filing contains only signature and cover-page XBRL information
- No substantive Regulation FD disclosure or investor-relevant operating update included
Item 8.01 · Other Events
- Scott Lloyd appointed Chief Commercial Officer effective October 5, 2026
- New role consolidates commercial strategy, sales, and provider and payor partnerships
- Lloyd brings nephrology strategy and durable medical equipment experience
- Appointment supports growth focus as Accendra scales its pure-play home-based care model
Item EX-99.1 · Exhibit EX-99.1
- Kenneth Gardner-Smith to become President and CEO early Q4 2026, succeeding retiring CEO Edward Pesicka
- Gardner-Smith’s board tenure since March 2022 supports continuity while bringing healthcare operating leadership from Veritas and DaVita
- Strategy emphasis: higher-margin growth categories, operating efficiency, and investment in Accendra’s pure-play home-based care platform
- Scott Lloyd appointed Chief Commercial Officer effective October 5, consolidating sales, commercial strategy, and provider-payor partnerships
- Pesicka to retire from the board but remain an advisor, reducing transition-disruption risk during leadership handoff
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.